A phase II study of interferon-α2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma

MZ Schultz, AC Buzaid, WJ Poo - Melanoma research, 1997 - journals.lww.com
A phase II trial was conducted to determine the efficacy and toxicity of the addition of
interferon-[alpha] 2b (IFN-a [alpha]) to the chemotherapy combination of dacarbazine …
被引用次数：15 相关文章

A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma

MZ Schultz, AC Buzaid, WJ Poo - Melanoma research, 1997 - pubmed.ncbi.nlm.nih.gov
A phase II trial was conducted to determine the efficacy and toxicity of the addition of
interferon-alpha 2b (IFN-alpha) to the chemotherapy combination of dacarbazine (DTIC) …

A phase II study of interferon-α2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma

MZ Schultz, AC Buzaid, WJ Poo - Melanoma …, 1997 - mdanderson.elsevierpure.com
A phase II trial was conducted to determine the efficacy and toxicity of the addition of
interferon-α2b (IFN-α) to the chemotherapy combination of dacarbazine (DTIC), carmustine …

A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma.

MZ Schultz, AC Buzaid, WJ Poo - Melanoma Research, 1997 - europepmc.org
A phase II trial was conducted to determine the efficacy and toxicity of the addition of
interferon-alpha 2b (IFN-alpha) to the chemotherapy combination of dacarbazine (DTIC) …

[引用][C] A phase II study of interferon-a2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma

MZ Schultz, AC Buzaid, W Poo - Melanoma Research, 1997